المؤلفون: Hussein, Humaira

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, SGLT-2i, glucagon-like peptide-1 receptor agonists (GLP-1 RAs), blood-glucose, Type 2 diabetes, thesis

الوصول الحر: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.890436Test

المصدر: Wills Eye Hospital Papers

مصطلحات الفهرس: diabetic retinopathy, glucagon-like peptide-1 receptor, retrospective studies, sodium-glucose transporter 2 inhibitors, Humans, Adult, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor, Diabetic Retinopathy, Retrospective Studies, Glucagon-Like Peptide 1, Glucose, Sodium, Endocrinology, Diabetes, and Metabolism, Medicine and Health Sciences, Ophthalmology, article

URL: https://jdc.jefferson.edu/willsfp/189Test
https://jdc.jefferson.edu/context/willsfp/article/1189/viewcontent/RefID_4481.pdfTest
https://jdc.jefferson.edu/context/willsfp/article/1189/filename/1/type/additional/viewcontent/dmj_2022_0221_Supplementary_Table_1.pdfTest
https://jdc.jefferson.edu/context/willsfp/article/1189/filename/2/type/additional/viewcontent/dmj_2022_0221_Supplementary_Table_2.pdfTest
https://jdc.jefferson.edu/context/willsfp/article/1189/filename/3/type/additional/viewcontent/dmj_2022_0221_Supplementary_Table_3.pdfTest
https://jdc.jefferson.edu/context/willsfp/article/1189/filename/4/type/additional/viewcontent/dmj_2022_0221_Supplementary_Table_4.pdfTest
https://jdc.jefferson.edu/context/willsfp/article/1189/filename/5/type/additional/viewcontent/dmj_2022_0221_Supplementary_Table_5.pdfTest
https://jdc.jefferson.edu/context/willsfp/article/1189/filename/6/type/additional/viewcontent/dmj_2022_0221_Supplementary_Table_6.pdfTest

مصطلحات الفهرس: Adverse events, Dose frequency, Glucagon-like peptide-1 receptor agonists, Injectable drugs, Nausea, Oral treatment, Route of delivery, Sodium–glucose co-transporter 2 inhibitors, Urogenital-tract infections, Weight loss, Aged, Body Weight, Choice Behavior, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Female, Glucagon-Like Peptide-1 Receptor, Humans, Hypoglycemic Agents, Italy, Male, Middle Aged, Patient Preference, Surveys and Questionnaires, Weight Loss, Dosage Forms, Settore MED/09 - MEDICINA INTERNA, info:eu-repo/semantics/article

URL: http://hdl.handle.net/10807/172111Test
info:eu-repo/semantics/altIdentifier/pmid/30306406
info:eu-repo/semantics/altIdentifier/wos/WOS:000459478700004
volume:56
issue:3
firstpage:289
lastpage:299
numberofpages:11
issueyear:2019
journal:ACTA DIABETOLOGICA

مصطلحات الفهرس: Body mass index, Visceral obesity, Obeticolic acid, Peroxisome proliferator-activated receptor, Glucagon-like peptide-1 receptor agonists, Índice de masa corporal, Obesidad visceral, Ácido obeticólico, Peroxisome proliferator activated receptor, Agonistas glucagon-like peptide-1 receptor, info:eu-repo/semantics/article

URL: https://hdl.handle.net/11441/108571Test
Revista Española De Enfermedades Digestivas, 41 (2), 128-142.

مصطلحات الفهرس: Body mass index, Visceral obesity, Obeticolic acid, Peroxisome proliferator-activated receptor, Glucagon-like peptide-1 receptor agonists, Índice de masa corporal, Obesidad visceral, Ácido obeticólico, Peroxisome proliferator activated receptor, Agonistas glucagon-like peptide-1 receptor, info:eu-repo/semantics/article

URL: https://hdl.handle.net/11441/108571Test
Revista Española De Enfermedades Digestivas, 41 (2), 128-142.

مصطلحات الفهرس: Body mass index, Visceral obesity, Obeticolic acid, Peroxisome proliferator-activated receptor, Glucagon-like peptide-1 receptor agonists, Índice de masa corporal, Obesidad visceral, Ácido obeticólico, Peroxisome proliferator activated receptor, Agonistas glucagon-like peptide-1 receptor, info:eu-repo/semantics/article

URL: Revista Española De Enfermedades Digestivas, 41 (2), 128-142.

مصطلحات الفهرس: Body mass index, Visceral obesity, Obeticolic acid, Peroxisome proliferator-activated receptor, Glucagon-like peptide-1 receptor agonists, Índice de masa corporal, Obesidad visceral, Ácido obeticólico, Peroxisome proliferator activated receptor, Agonistas glucagon-like peptide-1 receptor, info:eu-repo/semantics/article

URL: Revista Española De Enfermedades Digestivas, 41 (2), 128-142.

المؤلفون: Patel, Femina

المصدر: Cureus; vol 15, iss 8, e43773; 2168-8184

مصطلحات الفهرس: Biomedical and Clinical Sciences, Clinical Sciences, Prevention, Diabetes, Digestive Diseases, Obesity, Clinical Research, Autoimmune Disease, Metabolic and endocrine, Oral and gastrointestinal, Good Health and Well Being, abdominal pain, acute pancreatitis, glucagon-like peptide-1 receptor agonist, post-cholecystectomy, semaglutide, Medical and Health Sciences, Biomedical and clinical sciences, Health sciences, article

URL: https://escholarship.org/uc/item/8np2416wTest
https://escholarship.orgTest/

المصدر: on behalf of the FLOW Steering Committee and FLOW Trial Investigators 2023 , ' The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease ' , Nephrology Dialysis Transplantation , vol. 38 , no. 9 , pp. 2041-2051 .

مصطلحات الفهرس: albuminuria, cardiovascular disease, diabetic kidney disease, glomerular filtration rate, glucagon-like peptide-1 receptor agonist, article

URL: https://curis.ku.dk/portal/da/publications/the-rationale-design-and-baseline-data-of-flow-a-kidney-outcomes-trial-with-onceweekly-semaglutide-in-people-with-type-2-diabetes-and-chronic-kidney-diseaseTest(ea6daa6b-1f3c-4b69-82b5-235a7559a3e1).html
https://doi.org/10.1093/ndt/gfad009Test
https://curis.ku.dk/ws/files/371021719/gfad009.pdfTest

المصدر: Pottegård , A , Andersen , J H , Søndergaard , J , Thomsen , R W & Vilsbøll , T 2023 , ' Changes in the use of glucose-lowering drugs : A Danish nationwide study ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 4 , pp. 1002-1010 .

مصطلحات الفهرس: antidiabetics, drug utilization, glucagon-like peptide-1 receptor agonists, glucose-lowering medication, pharmacoepidemiology, sodium-glucose co-transporter-2 inhibitors, type 2 diabetes, article

URL: https://curis.ku.dk/portal/da/publications/changes-in-the-use-of-glucoselowering-drugsTest(11618378-6307-4061-a5a7-0e25d94c2c0b).html
https://doi.org/10.1111/dom.14947Test
https://curis.ku.dk/ws/files/342495143/Diabetes_Obesity_Metabolism_2022_Potteg_rd_Changes_in_the_use_of_glucose_lowering_drugs_A_Danish_nationwide_study.pdfTest